These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39030333)

  • 41. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
    Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
    Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway.
    Zhang F; Liu J; Xie BB
    J Cell Physiol; 2019 Aug; 234(10):18626-18638. PubMed ID: 31049956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-195-5p inhibits cisplatin resistance in lung adenocarcinoma by regulating DNA damage via targeting E2F7.
    Wu H; Zheng B
    J Biochem Mol Toxicol; 2024 Nov; 38(11):e70015. PubMed ID: 39415701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
    Shi J; Lu Y; Wei P
    J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.
    Yuan C; Bai R; Gao Y; Jiang X; Li S; Sun W; Li Y; Huang Z; Gong Y; Xie C
    Oxid Med Cell Longev; 2021; 2021():4522210. PubMed ID: 34925694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13.
    Wu X; Wang W; Wu G; Peng C; Liu J
    Comput Math Methods Med; 2021; 2021():7074343. PubMed ID: 34335864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
    Han J; Wang Y
    Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
    J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
    Xu Y; Chen X
    Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
    Li Y; Zhang H; Fan L; Mou J; Yin Y; Peng C; Chen Y; Lu H; Zhao L; Tao Z; Chen J; Wang Y; Qi X; Huang R; Ren J
    Oncogene; 2020 Apr; 39(17):3473-3488. PubMed ID: 32108166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
    Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis.
    Dong N; Gu WW; Yang L; Lian WB; Jiang J; Zhu HJ; Chen CS; Wang BB
    Int Immunopharmacol; 2024 Sep; 138():112547. PubMed ID: 38943969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.